High Serum PD-L1 Levels Are Associated with Poor Survival in Urothelial Cancer Patients Treated with Chemotherapy and Immune Checkpoint Inhibitor Therapy

SIMPLE SUMMARY: Advanced urothelial bladder cancer (BC) shows a heterogeneous response to both platinum and immune checkpoint inhibitor (ICI) therapies. The PD-1/PD-L1 signaling pathway represents an immune escape mechanism and tissue PD-L1 expression was shown to be associated with patients’ progno...

Descripción completa

Detalles Bibliográficos
Autores principales: Krafft, Ulrich, Olah, Csilla, Reis, Henning, Kesch, Claudia, Darr, Christopher, Grünwald, Viktor, Tschirdewahn, Stephan, Hadaschik, Boris, Horvath, Orsolya, Kenessey, Istvan, Nyirady, Peter, Varadi, Melinda, Modos, Orsolya, Csizmarik, Anita, Szarvas, Tibor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196869/
https://www.ncbi.nlm.nih.gov/pubmed/34067347
http://dx.doi.org/10.3390/cancers13112548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196869/
https://www.ncbi.nlm.nih.gov/pubmed/34067347
http://dx.doi.org/10.3390/cancers13112548

Ejemplares similares